Literature DB >> 9393396

Recommendations for management of trigeminal nerve defects based on a critical appraisal of the literature.

T B Dodson1, L B Kaban.   

Abstract

PURPOSE: Management of trigeminal nerve injuries continues to challenge oral and maxillofacial surgeons. The purpose of this review article is to apply the principles of evidence-based medicine (E-BM) to determine the optimal operative technique for managing defects involving the inferior alveolar (IAN) or lingual nerves when direct (ie, primary) repair is not feasible.
METHODS: To address the research purpose, the four steps of the E-BM critical appraisal process were applied: 1) identify the clinical problem, 2) efficiently search the literature, 3) select relevant articles and apply rules of evidence, and 4) apply the findings to patient care. Parameters for the literature search included using Medline to identify English language articles, publication dates from 1986 through 1996, and studies involving human subjects.
RESULTS: The studies reviewed showed that the clinical literature on operative management of trigeminal nerve injuries is sparse, preoperative and postoperative neurosensory examinations are poorly documented, and the data are derived completely from reports using case series methods. Given these limitations, the available literature suggests that 1) tension-free, primary (direct) suture repair of an injured nerve, if possible, provides optimal results; 2) if direct repair is not possible, autogenous nerve grafts should be used for acute injuries, for example, immediate nerve repair after tumor resection or at the time of acute repair after traumatic injury; and 3) if direct repair is not possible, autogenous nerve grafts or hollow conduits (entubulization) to bridge the defect are equally successful for delayed reconstruction of gaps of 3 cm or smaller.
CONCLUSIONS: Based on the weakness of the current literature, recommendations for future research include 1) better standardization and documentation of sensory deficits resulting from nerve injuries and their recovery, 2) using multicenter studies to accumulate large samples of patients rapidly, 3) using case series or prospective cohort study designs to assess the value of operative management of nerve injuries, and 4) progressing to randomized clinical trials to ascertain the optimal operative management of nerve injuries.

Entities:  

Mesh:

Year:  1997        PMID: 9393396     DOI: 10.1016/s0278-2391(97)90632-7

Source DB:  PubMed          Journal:  J Oral Maxillofac Surg        ISSN: 0278-2391            Impact factor:   1.895


  6 in total

1.  The prognostic value of histopathology on lingual nerve neurosensory recovery after micro-neurosurgery.

Authors:  Mette Hørberg; Jesper Reibel; Camilla Kragelund
Journal:  Clin Oral Investig       Date:  2015-07-09       Impact factor: 3.573

2.  Iatrogenic injury to oral branches of the trigeminal nerve: records of 449 cases.

Authors:  Søren Hillerup
Journal:  Clin Oral Investig       Date:  2006-12-22       Impact factor: 3.606

3.  Rehabilitation of the trigeminal nerve.

Authors:  Heinrich Iro; Klaus Bumm; Frank Waldfahrer
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2005-09-28

4.  Post-traumatic and postoperative neurosensory deficits of the inferior alveolar nerve in mandibular fracture: a prospective study.

Authors:  Sunil Yadav; Hitesh Chander Mittal; Sunita Malik; Vikas Dhupar; Akash Sachdeva; Vijaylaxmy Malhotra; Gurdarshan Singh
Journal:  J Korean Assoc Oral Maxillofac Surg       Date:  2016-10-25

5.  Protracted delay in taste sensation recovery after surgical lingual nerve repair: a case report.

Authors:  Kenji Seo; Yuji Inada; Makoto Terumitsu; Tatsuo Nakamura; Keiji Shigeno; Yutaka Tanaka; Tatsuru Tsurumaki; Shigenobu Kurata; Hitoshi Matsuzawa
Journal:  J Med Case Rep       Date:  2013-03-18

6.  Longitudinal Treatment Outcomes of Microsurgical Treatment of Neurosensory Deficit after Lower Third Molar Surgery: A Prospective Case Series.

Authors:  Yiu Yan Leung; Lim Kwong Cheung
Journal:  PLoS One       Date:  2016-03-04       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.